Statements (17)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:company
|
| gptkbp:CEO |
Rohan Palekar
|
| gptkbp:focus |
rare diseases
metabolic diseases |
| gptkbp:foundedYear |
2010
|
| gptkbp:fullName |
Axla Therapeutics, Inc.
|
| gptkbp:hasCompany |
true
|
| gptkbp:headquartersLocation |
gptkb:Cambridge,_Massachusetts,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
AXLA
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:product |
AXA1125
AXA1665 |
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
gptkb:AXLA
|
| gptkbp:website |
https://www.axlatx.com/
|
| gptkbp:bfsParent |
gptkb:Axcella_Health
|
| gptkbp:bfsLayer |
8
|